Atopic Dermatitis
Conference Coverage
Which children are at greatest risk for atopic dermatitis?
MADRID – Pediatric atopic dermatitis risk varies according to type of parental history of atopic disease.
From the Journals
Identifying bacterial infections in setting of atopic dermatitis
The high prevalence of S. aureus colonization and overlapping clinical features of atopic dermatitis and bacterial skin infections...
From the Journals
Fast, aggressive eczema treatment linked to fewer food allergies by age 2
Infants treated with corticosteroids for atopic dermatitis within 4 months of onset had half the food allergies as those treated later.
From the Journals
Atopic dermatitis in egg-, milk-allergic kids may up anaphylaxis risk
Egg- and milk- allergic patients with atopic dermatitis had more incidents of anaphylaxis; no impact seen in cases of peanut allergies.
Latest News
Frequent soaks ease pediatric atopic dermatitis
Twice-daily baths followed by occlusive moisturizer led to greater improvement.
From the Journals
Omalizumab proves effective for severe pediatric atopic dermatitis
Treatment with omalizumab for 24 weeks reduced severity and improved quality of life in pediatric patients with severe atopic dermatitis.
From the Journals
Naturopaths emphasize role of diet in atopic dermatitis
Allopathic and naturopathic providers diverge in opinions on the role of diet in cause and treatment of AD.
Conference Coverage
Atopic dermatitis acts differently in certain populations
LAS VEGAS – AD may require different treatments depending on age, ethnicity.
Conference Coverage
Oral baricitinib performs well in phase 3 for atopic dermatitis
MADRID – This is the first phase 3 study testing the efficacy of a JAK inhibitor in combination with low- and mid-potency topical steroids.
From the Journals
Early onset of atopic dermatitis linked to poorer control
Children who develop atopic dermatitis in the first 2 years of life are more likely to have poorly controlled or persistent disease.
Conference Coverage
IL-1 alpha is a new target in atopic dermatitis
MADRID – Bermekimab shows encouraging results in atopic dermatitis proof-of-concept study.